{"id":14319,"date":"2026-03-04T09:04:24","date_gmt":"2026-03-04T08:04:24","guid":{"rendered":"https:\/\/www.asssa.es\/ca\/?p=14319"},"modified":"2026-03-04T09:05:22","modified_gmt":"2026-03-04T08:05:22","slug":"tractament-artritis-reumatoide","status":"publish","type":"post","link":"https:\/\/www.asssa.es\/ca\/tractament-artritis-reumatoide\/","title":{"rendered":"Novetats en el tractament de l\u2019artritis reumatoide: medicaments biol\u00f2gics i el seu impacte"},"content":{"rendered":"<p><strong>L\u2019artritis reumatoide (AR) \u00e9s una malaltia autoimmune cr\u00f2nica<\/strong> que afecta les articulacions, causant inflamaci\u00f3, dolor, rigidesa i, amb el pas del temps, dany articular irreversible, arribant a la p\u00e8rdua de mobilitat i deformaci\u00f3 de les articulacions.<\/p>\n<p><!--more--><\/p>\n<p>Tot i que no t\u00e9 cura, els aven\u00e7os en el seu tractament han canviat radicalment el pron\u00f2stic de les persones que la pateixen, especialment gr\u00e0cies a l&#8217;arribada dels medicaments biol\u00f2gics.<\/p>\n<p>&nbsp;<\/p>\n<p><strong>Qu\u00e8 s\u00f3n els medicaments biol\u00f2gics?<\/strong><\/p>\n<p>Els tractaments biol\u00f2gics s\u00f3n <strong>f\u00e0rmacs desenvolupats mitjan\u00e7ant biotecnologia<\/strong> que actuen espec\u00edficament sobre mol\u00e8cules clau implicades en la resposta inflamat\u00f2ria del sistema immunitari. A difer\u00e8ncia dels f\u00e0rmacs tradicionals, que tenen un efecte m\u00e9s general, els biol\u00f2gics <strong>actuen de manera dirigida<\/strong>, la qual cosa permet una major efic\u00e0cia amb menys efectes adversos sist\u00e8mics, \u00e9s a dir, en tot l\u2019organisme.<\/p>\n<p>Aquests medicaments acostumen a administrar-se per via subcut\u00e0nia o intravenosa i estan indicats, principalment, en pacients que no han respost adequadament als tractaments convencionals, com el metotrexat (medicament).<\/p>\n<p>&nbsp;<\/p>\n<p><strong>Principals tipus de tractaments biol\u00f2gics<\/strong><\/p>\n<p>Hi ha diversos grups de medicaments biol\u00f2gics per a l\u2019AR, depenent de la mol\u00e8cula sobre la qual actuen:<\/p>\n<ul>\n<li><strong>Anti-TNF (factor de necrosi tumoral): <\/strong>com l\u2019adalimumab, l\u2019etanercept o l\u2019infliximab. S\u00f3n els m\u00e9s emprats i han demostrat reduir la inflamaci\u00f3 i frenar el dany articular amb efic\u00e0cia.<\/li>\n<li><strong>Anti-IL-6<\/strong>: com el tocilizumab, que bloqueja l&#8217;acci\u00f3 de la interleucina-6, una de les responsables principals del proc\u00e9s inflamatori en l\u2019AR.<\/li>\n<li><strong>Inhibidors de c\u00e8l\u00b7lules B o T:<\/strong> com el rituximab o l\u2019abatacept, que actuen modulant l\u2019activitat de determinats limf\u00f2cits implicats en la resposta immune.<\/li>\n<li><strong>Inhibidors de JAK (no biol\u00f2gics, per\u00f2 similars en funci\u00f3):<\/strong> tot i que no s\u00f3n biol\u00f2gics en sentit estricte, els inhibidors de JAK (com el tofacitinib o el baricitinib) representen una alternativa oral molt efica\u00e7 per a pacients amb AR moderada o greu.<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><strong>Com han canviat la gesti\u00f3 de l\u2019AR?<\/strong><\/p>\n<p><strong>La incorporaci\u00f3 d\u2019aquests tractaments ha suposat una aut\u00e8ntica revoluci\u00f3.<\/strong> Abans, molts pacients patien una discapacitat progressiva i irreversible. Actualment, amb un diagn\u00f2stic preco\u00e7 i gr\u00e0cies al gran ventall terap\u00e8utic, \u00e9s possible assolir la remissi\u00f3 cl\u00ednica o, com a m\u00ednim, un control important de la malaltia, millorant notablement la qualitat de vida.<\/p>\n<p>A m\u00e9s, s\u2019ha adoptat un enfocament de tractament conegut com a \u00ab<strong><em>treat to target<\/em><\/strong>\u00bb, que implica ajustar la medicaci\u00f3 fins a arribar a un objectiu terap\u00e8utic clar, com la remissi\u00f3 o una baixa activitat de la malaltia.<\/p>\n<p>&nbsp;<\/p>\n<p><strong>Consideracions importants<\/strong><\/p>\n<p>Tot i que els medicaments biol\u00f2gics han demostrat ser segurs i efica\u00e7os, <strong>el seu \u00fas requereix un seguiment de prop.<\/strong> Si es modula el sistema immunitari, s\u2019incrementa el risc d\u2019infeccions, de manera que \u00e9s crucial fer controls peri\u00f2dics i complir amb el calendari de vacunes recomanat.<\/p>\n<p><strong>En resum, els tractaments biol\u00f2gics han transformat la manera d\u2019abordar l\u2019artritis reumatoide, oferint una nova esperan\u00e7a per a milers de pacients arreu del m\u00f3n.<\/strong><\/p>\n<p style=\"text-align: right;\">Dr. Antonio Avil\u00e9s<\/p>\n<p style=\"text-align: right;\">Resident de reumatologia<\/p>\n<p style=\"text-align: right;\">Hospital General Dr. Balmis<\/p>\n<h6><strong><u><a href=\"https:\/\/www.asssa.es\/ca\/assegurances-salut\/\">ASSSA Assegurances de Salut<\/a><\/u><\/strong><\/h6>\n<h6><em>La informaci\u00f3 publicada en aquest mitj\u00e0 no substitueix ni complementa cap manera l\u2019atenci\u00f3 directa d\u2019un metge, ni el seu diagn\u00f2stic, ni el tractament que prescrigui; tampoc s\u2019ha d\u2019utilitzar per a l\u2019autodiagn\u00f2stic.<\/em><\/h6>\n<h6><em>L\u2019\u00fas que faci el lector d\u2019aquest servei es realitza sota la seva exclusiva responsabilitat.<\/em><\/h6>\n<h6><em>ASSSA recomana que per a qualsevol q\u00fcesti\u00f3 relacionada amb la seva salut consulti sempre amb un metge.<\/em><\/h6>\n","protected":false},"excerpt":{"rendered":"<p>L\u2019artritis reumatoide (AR) \u00e9s una malaltia autoimmune cr\u00f2nica que afecta les articulacions, causant inflamaci\u00f3, dolor, rigidesa i, amb el pas del temps, dany articular irreversible, arribant a la p\u00e8rdua de mobilitat i deformaci\u00f3 de les articulacions.<\/p>\n","protected":false},"author":17,"featured_media":14320,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[37],"tags":[],"class_list":["post-14319","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-cuida-de-la-teva-salut"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Novetats en el tractament de l\u2019artritis reumatoide: medicaments biol\u00f2gics i el seu impacte - ASSSA Catal\u00e1n<\/title>\n<meta name=\"description\" content=\"L\u2019artritis reumatoide (AR) \u00e9s una malaltia autoimmune cr\u00f2nica que afecta les articulacions, causant inflamaci\u00f3, dolor i rigidesa.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.asssa.es\/ca\/tractament-artritis-reumatoide\/\" \/>\n<meta property=\"og:locale\" content=\"ca_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Novetats en el tractament de l\u2019artritis reumatoide: medicaments biol\u00f2gics i el seu impacte - ASSSA Catal\u00e1n\" \/>\n<meta property=\"og:description\" content=\"L\u2019artritis reumatoide (AR) \u00e9s una malaltia autoimmune cr\u00f2nica que afecta les articulacions, causant inflamaci\u00f3, dolor i rigidesa.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.asssa.es\/ca\/tractament-artritis-reumatoide\/\" \/>\n<meta property=\"og:site_name\" content=\"ASSSA Catal\u00e1n\" \/>\n<meta property=\"article:published_time\" content=\"2026-03-04T08:04:24+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-03-04T08:05:22+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.asssa.es\/wp-content\/uploads\/2026\/03\/imagen-blog-artritis-3.png\" \/>\n\t<meta property=\"og:image:width\" content=\"600\" \/>\n\t<meta property=\"og:image:height\" content=\"297\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"anabisquert\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrit per\" \/>\n\t<meta name=\"twitter:data1\" content=\"anabisquert\" \/>\n\t<meta name=\"twitter:label2\" content=\"Temps estimat de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minuts\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.asssa.es\\\/ca\\\/tractament-artritis-reumatoide\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.asssa.es\\\/ca\\\/tractament-artritis-reumatoide\\\/\"},\"author\":{\"name\":\"anabisquert\",\"@id\":\"https:\\\/\\\/www.asssa.es\\\/ca\\\/#\\\/schema\\\/person\\\/28426677ce1ecdf429f899be3593c606\"},\"headline\":\"Novetats en el tractament de l\u2019artritis reumatoide: medicaments biol\u00f2gics i el seu impacte\",\"datePublished\":\"2026-03-04T08:04:24+00:00\",\"dateModified\":\"2026-03-04T08:05:22+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.asssa.es\\\/ca\\\/tractament-artritis-reumatoide\\\/\"},\"wordCount\":631,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/www.asssa.es\\\/ca\\\/tractament-artritis-reumatoide\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.asssa.es\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/imagen-blog-artritis-3.png\",\"articleSection\":[\"Cuida de la teva salut\"],\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.asssa.es\\\/ca\\\/tractament-artritis-reumatoide\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.asssa.es\\\/ca\\\/tractament-artritis-reumatoide\\\/\",\"url\":\"https:\\\/\\\/www.asssa.es\\\/ca\\\/tractament-artritis-reumatoide\\\/\",\"name\":\"Novetats en el tractament de l\u2019artritis reumatoide: medicaments biol\u00f2gics i el seu impacte - ASSSA Catal\u00e1n\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.asssa.es\\\/ca\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.asssa.es\\\/ca\\\/tractament-artritis-reumatoide\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.asssa.es\\\/ca\\\/tractament-artritis-reumatoide\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.asssa.es\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/imagen-blog-artritis-3.png\",\"datePublished\":\"2026-03-04T08:04:24+00:00\",\"dateModified\":\"2026-03-04T08:05:22+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.asssa.es\\\/ca\\\/#\\\/schema\\\/person\\\/28426677ce1ecdf429f899be3593c606\"},\"description\":\"L\u2019artritis reumatoide (AR) \u00e9s una malaltia autoimmune cr\u00f2nica que afecta les articulacions, causant inflamaci\u00f3, dolor i rigidesa.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.asssa.es\\\/ca\\\/tractament-artritis-reumatoide\\\/#breadcrumb\"},\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.asssa.es\\\/ca\\\/tractament-artritis-reumatoide\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\\\/\\\/www.asssa.es\\\/ca\\\/tractament-artritis-reumatoide\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.asssa.es\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/imagen-blog-artritis-3.png\",\"contentUrl\":\"https:\\\/\\\/www.asssa.es\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/imagen-blog-artritis-3.png\",\"width\":600,\"height\":297},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.asssa.es\\\/ca\\\/tractament-artritis-reumatoide\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\\\/\\\/www.asssa.es\\\/ca\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Novetats en el tractament de l\u2019artritis reumatoide: medicaments biol\u00f2gics i el seu impacte\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.asssa.es\\\/ca\\\/#website\",\"url\":\"https:\\\/\\\/www.asssa.es\\\/ca\\\/\",\"name\":\"ASSSA Catal\u00e1n\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.asssa.es\\\/ca\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ca\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.asssa.es\\\/ca\\\/#\\\/schema\\\/person\\\/28426677ce1ecdf429f899be3593c606\",\"name\":\"anabisquert\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/e9cae4df96875fce5fb542f19394d31947278addfbdcdc1f4b3381f226af94d5?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/e9cae4df96875fce5fb542f19394d31947278addfbdcdc1f4b3381f226af94d5?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/e9cae4df96875fce5fb542f19394d31947278addfbdcdc1f4b3381f226af94d5?s=96&d=mm&r=g\",\"caption\":\"anabisquert\"},\"url\":\"https:\\\/\\\/www.asssa.es\\\/ca\\\/author\\\/anabisquert\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Novetats en el tractament de l\u2019artritis reumatoide: medicaments biol\u00f2gics i el seu impacte - ASSSA Catal\u00e1n","description":"L\u2019artritis reumatoide (AR) \u00e9s una malaltia autoimmune cr\u00f2nica que afecta les articulacions, causant inflamaci\u00f3, dolor i rigidesa.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.asssa.es\/ca\/tractament-artritis-reumatoide\/","og_locale":"ca_ES","og_type":"article","og_title":"Novetats en el tractament de l\u2019artritis reumatoide: medicaments biol\u00f2gics i el seu impacte - ASSSA Catal\u00e1n","og_description":"L\u2019artritis reumatoide (AR) \u00e9s una malaltia autoimmune cr\u00f2nica que afecta les articulacions, causant inflamaci\u00f3, dolor i rigidesa.","og_url":"https:\/\/www.asssa.es\/ca\/tractament-artritis-reumatoide\/","og_site_name":"ASSSA Catal\u00e1n","article_published_time":"2026-03-04T08:04:24+00:00","article_modified_time":"2026-03-04T08:05:22+00:00","og_image":[{"width":600,"height":297,"url":"https:\/\/www.asssa.es\/wp-content\/uploads\/2026\/03\/imagen-blog-artritis-3.png","type":"image\/png"}],"author":"anabisquert","twitter_card":"summary_large_image","twitter_misc":{"Escrit per":"anabisquert","Temps estimat de lectura":"4 minuts"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.asssa.es\/ca\/tractament-artritis-reumatoide\/#article","isPartOf":{"@id":"https:\/\/www.asssa.es\/ca\/tractament-artritis-reumatoide\/"},"author":{"name":"anabisquert","@id":"https:\/\/www.asssa.es\/ca\/#\/schema\/person\/28426677ce1ecdf429f899be3593c606"},"headline":"Novetats en el tractament de l\u2019artritis reumatoide: medicaments biol\u00f2gics i el seu impacte","datePublished":"2026-03-04T08:04:24+00:00","dateModified":"2026-03-04T08:05:22+00:00","mainEntityOfPage":{"@id":"https:\/\/www.asssa.es\/ca\/tractament-artritis-reumatoide\/"},"wordCount":631,"commentCount":0,"image":{"@id":"https:\/\/www.asssa.es\/ca\/tractament-artritis-reumatoide\/#primaryimage"},"thumbnailUrl":"https:\/\/www.asssa.es\/wp-content\/uploads\/2026\/03\/imagen-blog-artritis-3.png","articleSection":["Cuida de la teva salut"],"inLanguage":"ca","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.asssa.es\/ca\/tractament-artritis-reumatoide\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.asssa.es\/ca\/tractament-artritis-reumatoide\/","url":"https:\/\/www.asssa.es\/ca\/tractament-artritis-reumatoide\/","name":"Novetats en el tractament de l\u2019artritis reumatoide: medicaments biol\u00f2gics i el seu impacte - ASSSA Catal\u00e1n","isPartOf":{"@id":"https:\/\/www.asssa.es\/ca\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.asssa.es\/ca\/tractament-artritis-reumatoide\/#primaryimage"},"image":{"@id":"https:\/\/www.asssa.es\/ca\/tractament-artritis-reumatoide\/#primaryimage"},"thumbnailUrl":"https:\/\/www.asssa.es\/wp-content\/uploads\/2026\/03\/imagen-blog-artritis-3.png","datePublished":"2026-03-04T08:04:24+00:00","dateModified":"2026-03-04T08:05:22+00:00","author":{"@id":"https:\/\/www.asssa.es\/ca\/#\/schema\/person\/28426677ce1ecdf429f899be3593c606"},"description":"L\u2019artritis reumatoide (AR) \u00e9s una malaltia autoimmune cr\u00f2nica que afecta les articulacions, causant inflamaci\u00f3, dolor i rigidesa.","breadcrumb":{"@id":"https:\/\/www.asssa.es\/ca\/tractament-artritis-reumatoide\/#breadcrumb"},"inLanguage":"ca","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.asssa.es\/ca\/tractament-artritis-reumatoide\/"]}]},{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.asssa.es\/ca\/tractament-artritis-reumatoide\/#primaryimage","url":"https:\/\/www.asssa.es\/wp-content\/uploads\/2026\/03\/imagen-blog-artritis-3.png","contentUrl":"https:\/\/www.asssa.es\/wp-content\/uploads\/2026\/03\/imagen-blog-artritis-3.png","width":600,"height":297},{"@type":"BreadcrumbList","@id":"https:\/\/www.asssa.es\/ca\/tractament-artritis-reumatoide\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/www.asssa.es\/ca\/"},{"@type":"ListItem","position":2,"name":"Novetats en el tractament de l\u2019artritis reumatoide: medicaments biol\u00f2gics i el seu impacte"}]},{"@type":"WebSite","@id":"https:\/\/www.asssa.es\/ca\/#website","url":"https:\/\/www.asssa.es\/ca\/","name":"ASSSA Catal\u00e1n","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.asssa.es\/ca\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ca"},{"@type":"Person","@id":"https:\/\/www.asssa.es\/ca\/#\/schema\/person\/28426677ce1ecdf429f899be3593c606","name":"anabisquert","image":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/secure.gravatar.com\/avatar\/e9cae4df96875fce5fb542f19394d31947278addfbdcdc1f4b3381f226af94d5?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9cae4df96875fce5fb542f19394d31947278addfbdcdc1f4b3381f226af94d5?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9cae4df96875fce5fb542f19394d31947278addfbdcdc1f4b3381f226af94d5?s=96&d=mm&r=g","caption":"anabisquert"},"url":"https:\/\/www.asssa.es\/ca\/author\/anabisquert\/"}]}},"jetpack_featured_media_url":"https:\/\/www.asssa.es\/wp-content\/uploads\/2026\/03\/imagen-blog-artritis-3.png","_links":{"self":[{"href":"https:\/\/www.asssa.es\/ca\/wp-json\/wp\/v2\/posts\/14319","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.asssa.es\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.asssa.es\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.asssa.es\/ca\/wp-json\/wp\/v2\/users\/17"}],"replies":[{"embeddable":true,"href":"https:\/\/www.asssa.es\/ca\/wp-json\/wp\/v2\/comments?post=14319"}],"version-history":[{"count":2,"href":"https:\/\/www.asssa.es\/ca\/wp-json\/wp\/v2\/posts\/14319\/revisions"}],"predecessor-version":[{"id":14322,"href":"https:\/\/www.asssa.es\/ca\/wp-json\/wp\/v2\/posts\/14319\/revisions\/14322"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.asssa.es\/ca\/wp-json\/wp\/v2\/media\/14320"}],"wp:attachment":[{"href":"https:\/\/www.asssa.es\/ca\/wp-json\/wp\/v2\/media?parent=14319"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.asssa.es\/ca\/wp-json\/wp\/v2\/categories?post=14319"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.asssa.es\/ca\/wp-json\/wp\/v2\/tags?post=14319"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}